Clin2
NCT07809945Possibly a fitNot yet recruiting

Weight loss study for people with overweight or obesity

Obesity and Overweight

Part of Hormones & metabolism clinical trials.

This study tests a new medication called IBI3046 for people who are overweight or have obesity. The purpose is to see if it helps with weight loss and works safely.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
128 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • Your BMI (a measure of body fat) is between 24 and 40.
  • Your weight has been stable (no more than 5% change) in the last 3 months.
  • You have not been diagnosed with diabetes or abnormal blood sugar.
  • You have not had pancreatitis, thyroid problems, or certain hormone-related conditions.
  • You have not had cancer (other than some skin cancers) in the past 5 years.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07793019Recruiting· Phase 1
Weight loss and safety study in overweight adults

This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.

Beijing, Beijing Municipality
NCT07648225Not yet recruiting· Phase 3
Weight loss injection study for overweight or obesity

This study tests an investigational injection called UBT251 to help people who are overweight or obese lose weight. It may also improve related health issues like high blood pressure or fatty liver. The trial lasts for a period and includes regular check-ins with the study team.

Beijing
NCT07802899Not yet recruiting· Phase 1
Early study of a new drug for overweight or obese adults

This study tests an experimental drug called IBI3042 in healthy people who are normal weight, overweight, or obese. It is an early-stage trial looking at how safe and tolerable the drug is, and how it affects the body, which could eventually lead to a treatment for weight loss.

Luoyang, Hennan
NCT07754474Recruiting· Phase 1
Testing a new medicine for overweight or obesity

This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.

Mannheim
NCT07765160Not yet recruiting· Phase 1
Study of IBI3040 in healthy and overweight or obese adults

This study tests an investigational drug called IBI3040 in healthy adults and in adults who are overweight or obese. It aims to see how the drug affects the body, which may help with weight management. Participants will be monitored closely throughout the study.

Shanghai, Shanghai Municipality
NCT07378033Enrolling by invitation
Body fat reduction and weight management study

This study tests a new approach to help with weight loss and body fat reduction. It may be a good fit if you are an adult with a BMI in the overweight to moderately obese range and you are not currently using weight-loss medications.

Bangalore, Karnataka

Hear when a new Obesity and Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.